Suppr超能文献

抗菌药物耐药性——药理学解决方案

Antimicrobial resistance--pharmacological solutions.

作者信息

Rubinstein E

机构信息

Infectious Diseases Unit, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

出版信息

Infection. 1999;27 Suppl 2:S32-4. doi: 10.1007/BF02561668.

Abstract

The interaction between microbial resistance and antibacterial agents occurs in a direct and an indirect fashion. Directly--through the development of resistance to the agent used, or to agents of the same class--as exemplified by the induction of beta-lactamase by both gram-positive and gram-negative bacteria. It also takes place through the development of resistance to compounds of different classes to the compound used, as exemplified by the loss of Streptococcus pneumoniae susceptibility to penicillin that is accompanied by a parallel loss of sensitivity to erythromycin and to tetracycline. As for the indirect way--microbial resistance may develop through selection of resistant organisms when the patient is treated with antibiotics, when the environment is contaminated with antibiotics (hospital) or when antibacterial agents are used in agriculture and animal husbandry.

摘要

微生物耐药性与抗菌药物之间的相互作用以直接和间接两种方式发生。直接方式是指通过对所用药物或同类药物产生耐药性,例如革兰氏阳性菌和革兰氏阴性菌诱导产生β-内酰胺酶。这种相互作用也可通过对与所用化合物不同类别的化合物产生耐药性来体现,例如肺炎链球菌对青霉素的敏感性丧失,同时对红霉素和四环素的敏感性也相应丧失。至于间接方式,当患者接受抗生素治疗、环境被抗生素污染(医院)或抗菌药物用于农业和畜牧业时,耐药微生物可能通过选择耐药菌而产生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验